Ellerson Group’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.94M | Sell |
121,493
-325
| -0.3% | -$7.88K | 2.08% | 19 |
|
|
2025
Q1 | $3.09M | Sell |
121,818
-1,604
| -1% | -$40.6K | 2.45% | 20 |
|
|
2024
Q4 | $3.27M | Sell |
123,422
-5,600
| -4% | -$149K | 2.39% | 18 |
|
|
2024
Q3 | $3.73M | Sell |
129,022
-3,435
| -3% | -$99.4K | 2.93% | 13 |
|
|
2024
Q2 | $3.71M | Buy |
132,457
+165
| +0.1% | +$4.62K | 2.82% | 13 |
|
|
2024
Q1 | $3.67M | Sell |
132,292
-1,280
| -1% | -$35.5K | 2.81% | 13 |
|
|
2023
Q4 | $3.85M | Buy |
133,572
+119,262
| +833% | +$3.43M | 3.34% | 11 |
|
|
2023
Q3 | $475K | Buy |
14,310
+3,160
| +28% | +$105K | 0.44% | 36 |
|
|
2023
Q2 | $409K | Sell |
11,150
-800
| -7% | -$29.3K | 0.39% | 36 |
|
|
2023
Q1 | $488K | Sell |
11,950
-69,775
| -85% | -$2.85M | 0.53% | 27 |
|
|
2022
Q4 | $4.19M | Buy |
+81,725
| New | +$4.19M | 4.44% | 5 |
|